HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Rose Sheet

Executive Summary

NICEATM seeks public comments on priorities for reducing, refining and replacing animal tests. POLA Orbis acquires Jurlique, P&G introduces new beauty and fashion website.

You may also be interested in...



New Products In Brief

Inter Parfums/Banana Republic roll out two new evening- and marine-inspired fragrances, Wildbloom Rouge and Wildblue Noir, while Chattem launches its trusted Gold Bond formula in a user-friendly, no-mess spray. More new products in brief.

Natural Brands Open Concept Stores In Asia, Skirt Distribution Challenges

Organic Monitor identifies Australian brands Jurlique and Jasmin Aromatique among foreign natural/organic brands getting their foot into Asian personal-care markets by launching their own concept stores instead of seeking distributors. The route allows brands to educate consumers themselves, among other benefits.

NICEATM Readies 5-Year Plan For Congress; Director Stokes Discusses

The National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is finalizing its five-year plan for submission to federal House and Senate appropriations committees by year-end, according to director William S. Stokes, DVM

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017875

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel